Page 116 - CPG - Clinical Practice Guidelines - Management of Cancer Pain

Management of Cancer Pain (Second Edition)
/,67 2) $%%5(9,$7,216

AEs adverse effects
ATC around-the-clock
AUC area under the curve
BD two times a day
BPI Brief Pain Inventory
%4 ,, 7KH %DUULHUV 4XHVWLRQQDLUH ,,
CAM complementary and alternative medicine
&*$ FRUUHFWHG JHVWDWLRQDO DJH
&, FRQ¿GHQFH LQWHUYDO
&3* &OLQLFDO 3UDFWLFH *XLGHOLQHV
&31 FRHOLDF SOH[XV QHXURO\VLV
&16 FHQWUDO QHUYRXV V\VWHP
COMM Current Opioid Misuse Measure
&2; F\FORR[\JHQDVH
CR controlled-release
CrCL Creatinine Clearance
CV cardiovascular
DN4 Doeleur Neuropathique en 4
(%57 H[WHUQDO EHDP WKHUDS\
H*)5 HVWLPDWHG JORPHUXODU ¿OWUDWLRQ UDWH
EPCRC European Palliative Care Research Collaborative
(6$6 (GPRQWRQ 6\PSWRP $VVHVVPHQW 6\VWHP
(6$6 &6 (GPRQWRQ 6\PSWRP $VVHVVPHQW 6\VWHP ZLWK DGGLWLRQDO V\PSWRPV
RI FRQVWLSDWLRQ VOHHS DQG DGGHG WLPH ZLQGRZ RI ³SDVW KRXUV´
(6$6 U &6 (GPRQWRQ 6\PSWRP $VVHVVPHQW 6\VWHP ZLWK D WLPH ZLQGRZ RI ³QRZ´
FLACC Face Legs Activity Cry Consolability
)36 )DFHV 3DLQ 6FDOH
)67 IHQWDQ\O VXEOLQJXDO WDEOHWV
g gramme
*, JDVWURLQWHVWLQDO
*5$'( *UDGLQJ 5HFRPPHQGDWLRQV $VVHVVPHQW 'HYHORSPHQW DQG (YDOXDWLRQ
*\ *UD\ XQLW RI LRQLVLQJ UDGLDWLRQ GRVH
,$63 ,QWHUQDWLRQDO $VVRFLDWLRQ IRU WKH 6WXG\ RI 3DLQ
,326 ,QWHJUDWHG 3DOOLDWLYH &DUH 2XWFRPH 6FDOH
IR immediate release
IV intravenous
kg kilogramme
/$166 7KH /HHGV $VVHVVPHQW RI 1HXURSDWKLF 6\PSWRPV DQG 6LJQV
PD[ PD[LPXP
mcg microgramme
MD mean difference
MEDD morphine milligramme equivalent daily dose
mg milligramme
min minute
ml milliliter
034 0F*LOO 3DLQ 4XHVWLRQQDLUH
06$6 0HPRULDO 6\PSWRP $VVHVVPHQW 6FDOH
0 * PRUSKLQH JOXFXURQLGH
0 * PRUSKLQH JOXFXURQLGH

98

e-cpg inside text-Cancer pain-25/5/24.indd 98 09/08/2024 12:09 AM